BioVie Inc. presented its SUNRISE-PD trial's patient-centric design at the ATMRD Congress, enhancing access for Parkinson's patients. BioVie Inc. announced that a poster on its SUNRISE-PD Phase 2 ...
CARSON CITY, Nev., June 26, 2025 (GLOBE NEWSWIRE) -- BioVie Inc. (BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for the treatment of neurological and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback